ALLIANCEBERNSTEIN L.P. - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 101 filers reported holding XERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.0%.

Quarter-by-quarter ownership
ALLIANCEBERNSTEIN L.P. ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2021$158,000
-8.7%
35,1000.0%0.00%
Q4 2020$173,000
-16.8%
35,1000.0%0.00%
Q3 2020$208,000
+123.7%
35,1000.0%0.00%
Q2 2020$93,000
+132.5%
35,100
+71.2%
0.00%
Q1 2020$40,000
-72.4%
20,5000.0%0.00%
Q4 2019$145,000
-28.2%
20,5000.0%0.00%
Q3 2019$202,000
+2.0%
20,500
+18.5%
0.00%
Q2 2019$198,00017,3000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Redmile Group, LLC 3,000,641$29,496,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,308,666$22,694,0000.92%
ArrowMark Colorado Holdings LLC 1,656,422$16,283,0000.16%
IHT Wealth Management, LLC 57,028$561,0000.08%
MOORE CAPITAL MANAGEMENT, LP 50,000$492,0000.02%
Engineers Gate Manager LP 20,264$199,0000.01%
FEDERATED HERMES, INC. 300,000$2,949,0000.01%
FMR LLC 4,048,102$39,793,0000.01%
Invesco Ltd. 1,000,000$9,830,0000.00%
MetLife Investment Management, LLC 14,041$138,0230.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders